Methods of use of gamma inhibitor compounds for the attenuation of pain

Details for Australian Patent Application No. 2008237138 (hide)

Owner KAI Pharmaceuticals, Inc.

Inventors Harrison, Stephen D.

Agent Griffith Hack

Pub. Number AU-A-2008237138

PCT Pub. Number WO2008/124698

Priority 60/910,588 06.04.07 US

Filing date 7 April 2008

Wipo publication date 16 October 2008

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/7012 (2006.01) - Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

Event Publications

5 November 2009 PCT application entered the National Phase

  PCT publication WO2008/124698 Priority application(s): WO2008/124698

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008237153-A system and method capable of navigating and/or mapping any multidimensional space

2008237136-Blood pump system